Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Open accessAbstract
Heterozygous somatic mutations in the spliceosome gene U2AF1 occur in ∼ 11% of patients with myelodysplastic syndromes (MDS), the most common adult myeloid malignancy. It is unclear how these mutations contribute to disease. We examined in vivo hematopoietic consequences of the most common U2AF1 mutation using a doxycycline-inducible transgenic mouse model. Mice expressing mutant U2AF1(S34F) display altered hematopoiesis and changes in pre-mRNA splicing in hematopoietic progenitor cells by whole transcriptome analysis (RNA-seq). Integration with human RNA-seq datasets determined that common mutant U2AF1-induced splicing alterations are enriched in RNA processing genes, ribosomal genes, and recurrently mutated MDS and acute myeloid leukemia-associated genes. These findings support the hypothesis that mutant U2AF1 alters downstream gene isoform expression, thereby contributing to abnormal hematopoiesis in patients with MDS.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HSCs from mice mutant for Sf3b1, Srsf2, and U2af1 have a competitive disadvantage in vivo, unlike the clonal expansion observed in humans with these mutations.
“HSCs from mice mutant for these genes, Sf3b1 56, Srsf2 57, and U2af1 58, have a competitive disadvantage in vivo, unlike the clonal expansion observed in humans with these mutations.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581 · see citing works
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · see citing works
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · see citing works
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400 · see citing works
Gene ontology analysis for RNA-seq: accounting for selection bias
Young, M. D., Wakefield, M. J., Smyth, G. K., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-2-r14 · Cited by 7,107 · see citing works
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419 · see citing works
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665 · see citing works
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029 · see citing works
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832 · see citing works
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627 · see citing works
Detecting differential usage of exons from RNA-seq data
Anders, S., Reyes, A., & Huber, W. (2012) · Genome Research · doi:10.1101/gr.133744.111 · Cited by 1,545 · see citing works
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532 · see citing works
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222 · see citing works
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Ebert, B. L., Pretz, J. L., Bosco, J., Chang, C. Y., Tamayo, P., Galili, N., Raza, A., Root, D. E., Attar, E. C., Ellis, S. R., et al. (2008) · Nature · doi:10.1038/nature06494 · Cited by 925 · see citing works
Flicek, P., Ahmed, I., Amode, M. R., Barrell, D. G., Beal, K. M., Brent, S., Carvalho‐Silva, D., Clapham, P., Coates, G. M. P., Fairley, S., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1236 · Cited by 869 · see citing works
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Shirai, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2011) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 582 · see citing works
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., & Lehner, B. (2014) · Cell · doi:10.1016/j.cell.2014.01.051 · Cited by 557 · see citing works
Skourti-Stathaki, K., & Proudfoot, N. J. (2014) · Genes & Development · doi:10.1101/gad.242990.114 · Cited by 521 · see citing works
Beard, C., Hochedlinger, K., Plath, K., Wutz, A., & Jaenisch, R. (2006) · genesis · doi:10.1002/gene.20180 · Cited by 482 · see citing works
400: A Method for Combining Non-Independent, One-Sided Tests of Significance
Brown, M. B. (1975) · Biometrics · doi:10.2307/2529826 · Cited by 473 · see citing works
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity
Chia, N., Chan, Y.-S., Feng, B., Lu, X., Orlov, Y. L., Moreau, D., Kumar, P., Yang, L., Jiang, J., Lau, M.-S., et al. (2010) · Nature · doi:10.1038/nature09531 · Cited by 461 · see citing works
Functional recognition of the 3′ splice site AG by the splicing factor U2AF35
Wu, S., ROMFO, C. M., Nilsen, T. W., & Green, M. R. (1999) · Nature · doi:10.1038/45590 · Cited by 457 · see citing works
Raza, A., Gezer, S., Mundle, S. D., Gao, X., Alvi, S., Borok, R. Z., Rifkin, S., Iftikhar, A., Shetty, V., & Parcharidou, A. (1995) · Blood · doi:10.1182/blood.v86.1.268.bloodjournal861268 · Cited by 424 · see citing works
Thol, F. R., Kade, S., Schlarmann, C., Löffeld, P., Morgan, M. A., Krauter, J., Włodarski, M. W., Kölking, B., Wichmann, M., Görlich, K., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399337 · Cited by 420 · see citing works
Diffusion mechanisms in metallic supercooled liquids and glasses
Tang, X., Geyer, U., Busch, R., Johnson, W. L., & Wu, Y. H. (1999) · Nature · doi:10.1038/45996 · Cited by 343 · see citing works
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndrome
Barlow, J. L., Drynan, L. F., Hewett, D. R., Holmes, L. R., Lorenzo-Abalde, S., Lane, A. L., Jolin, H. E., Pannell, R., Middleton, A. J., Wong, S. H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2063 · Cited by 337 · see citing works
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Abdel-Wahab, O. I., Gao, J., Adli, M., Dey, A., Trimarchi, T., Chung, Y. R., Kuscu, C., Hricik, T., Ndiaye‐Lobry, D., LaFave, L. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131141 · Cited by 322 · see citing works
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
Woll, P. S., Kjällquist, U., Chowdhury, O., Doolittle, H., Wedge, D. C., Thongjuea, S., Erlandsson, R., Ngara, M., Anderson, K., Deng, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.036 · Cited by 317 · see citing works
U2AF1 mutations alter splice site recognition in hematological malignanciesPreprint
Ilagan, J. O., Ramakrishnan, A., Hayes, B. J., Murphy, M. E., Zebari, A. S., Bradley, P. H., & Bradley, R. K. (2014) · Genome Research · doi:10.1101/gr.181016.114 · Cited by 285 · see citing works
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284 · cited 12× · see citing works
“Mutations in spliceosome genes have been identified in over half of MDS patient bonemarrow samples, making it the most common class of genes mutated in MDS (Damm et al., 2012; Graubert et al., 2012; Papaemmanuil et al., 2011; Thol et al., 2012; Visconte et al., 2012; Walter et al., 2013; Yoshida et al., 2011).”
InfluentialHematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222861110 · Cited by 277 · see citing works
Epidemiology of Myelodysplastic Syndromes
Ma, X. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.04.014 · Cited by 237 · see citing works
Damm, F., Kosmider, O., Gelsi‐Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della-Valle, V., Couronné, L., Scourzic, L., Chesnais, V., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400994 · Cited by 232 · see citing works
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
Visconte, V., Makishima, H., Jankowska, A. M., Szpurka, H., Traina, F., Jerez, A., O'Keefe, C., Rogers, H. J., Sekeres, M. A., Maciejewski, J. P., et al. (2011) · Leukemia · doi:10.1038/leu.2011.232 · Cited by 212 · see citing works
MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency
Gaspar‐Maia, A., Qadeer, Z. A., Hasson, D., Ratnakumar, K., Leu, N. A., LeRoy, G., Liu, S., Costanzi, C., Valle‐García, D., Schaniel, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms2582 · Cited by 199 · see citing works
The histone variant macroH2A is an epigenetic regulator of key developmental genes
Buschbeck, M., Uribesalgo, I., Wibowo, I., Rué, P., Martin, D., Gutierrez, A., Morey, L., Guigó, R., López-Schier, H., & Di Croce, L. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1665 · Cited by 192 · see citing works
Brooks, A. N., Choi, P. S., de Waal, L. M., Sharifnia, T., Imielinski, M. B., Saksena, G., Pedamallu, C. S., Sivachenko, A., Rosenberg, M. W., Chmielecki, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087361 · Cited by 171 · see citing works
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Przychodzen, B. P., Jerez, A., Guinta, K. M., Sekeres, M. A., Padgett, R. A., Maciejewski, J. P., & Makishima, H. (2013) · Blood · doi:10.1182/blood-2013-01-480970 · Cited by 149 · see citing works
Building Robust Transcriptomes with Master Splicing Factors
Jangi, M., & Sharp, P. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.054 · Cited by 141 · see citing works
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
Okeyo-Owuor, T., White, B. S., Chatrikhi, R., Mohan, D. R., Kim, S. P., Griffith, M., Ding, L., Ketkar-Kulkarni, S., Hundal, J., Laird, K. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.303 · Cited by 135 · see citing works
Raza, A., Mundle, S. D., Iftikhar, A., Gregory, S. A., Marcus, B., Khan, Z., Alvi, S., Shetty, V. T., Dameron, S., Wright, V. J., et al. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830480302 · Cited by 128 · see citing works
Yoshida, Y. (1993) · PubMed · Cited by 114 · see citing works
Mechanisms of genome instability induced by RNA-processing defects
Chan, Y. A., Hieter, P., & Stirling, P. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.03.005 · Cited by 94 · see citing works
Pellagatti, A., Hellström‐Lindberg, E., Giagounidis, A. A. N., Perry, J., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Fidler, C., Cazzola, M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07178.x · Cited by 92 · see citing works
The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor
Srinivasan, R. S., de Erkenez, A. C., & Hemenway, C. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206361 · Cited by 90 · see citing works
Myelodysplasic syndromes: A comprehensive review
Catenacci, D. V. T., & Schiller, G. J. (2005) · Blood Reviews · doi:10.1016/j.blre.2005.01.004 · Cited by 89 · see citing works
Shetty, V. T., Hussaini, S., Broady-Robinson, L., Allampallam, K., Mundle, S. D., Borok, R. Z., Broderick, E., Mazzoran, L., Zorat, F., & Raza, A. (2000) · Blood · doi:10.1182/blood.v96.4.1388 · Cited by 79 · see citing works
PICALM–MLLT10 acute myeloid leukemia: A French cohort of 18 patients
Borel, C., Dastugue, N., Cances-Lauwers, V., Mozziconacci, J., Prébet, T., Vey, N., Pigneux, A., Lippert, É., Visanica, S., Legrand, F., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.07.008 · Cited by 55 · see citing works
Bacher, U., Haferlach, T., Schnittger, S., Zenger, M., Meggendorfer, M., Jeromin, S., Roller, A., Großmann, V., Krauth, M., Alpermann, T., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12710 · Cited by 50 · see citing works
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation
Eisfeld, A., Schwind, S., Hoag, K. W., Walker, C. J., Liyanarachchi, S., Patel, R. K., Huang, X., Markowitz, J., Duan, W., Otterson, G. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401727111 · Cited by 33 · see citing works
Hamblin, T. J. (1992) · Leukemia Research · doi:10.1016/0145-2126(92)90106-h · Cited by 33 · see citing works
Myelodysplastic syndromes in the United States: an update for clinicians
Troy, J. D., Atallah, E. L., Geyer, J. T., & Saber, W. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.898863 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Predicting splicing from primary sequence with deep learning
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., Schwartz, G. B., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.015 · Cited by 2,853 · see citing works
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156 · see citing works
“HSCs from mice mutant for these genes, Sf3b1 (57), Srsf2 (58), and U2af1 (59), have a competitive disadvantage in vivo, unlike the clonal expansion observed in humans with these mutations.”
BackgroundScotti, M. M., & Swanson, M. S. (2015) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,130 · see citing works
Goodall, G. J., & Wickramasinghe, V. O. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,070 · see citing works
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S., López‐Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 741 · see citing works
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E. H., Abdel-Wahab, O. I., & Bradley, R. K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.51 · Cited by 684 · see citing works
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579 · see citing works
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 503 · see citing works
Cazzola, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1904794 · Cited by 496 · see citing works
Clinical significance of somatic mutation in unexplained blood cytopenia
Malcovati, L., Gallì, A., Travaglino, E., Ambaglio, I., Rizzo, E., Molteni, E., Elena, C., Ferretti, V. V., Catricalà, S., Bono, E. B., et al. (2017) · Blood · doi:10.1182/blood-2017-01-763425 · Cited by 476 · see citing works
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
Sveen, A., Kilpinen, S. K., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I. (2015) · Oncogene · doi:10.1038/onc.2015.318 · Cited by 463 · see citing works
Darman, R. B., Seiler, M., Agrawal, A. A., Lim, K., Peng, S., Aird, D. R., Bailey, S., Bhavsar, E. B., Chan, B., Colla, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.053 · Cited by 455 · see citing works
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
Grimwade, D. J., Ivey, A., & Huntly, B. J. P. (2015) · Blood · doi:10.1182/blood-2015-07-604496 · Cited by 451 · see citing works
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386 · see citing works
Obeng, E. A., Chappell, R. J., Seiler, M., Chen, M. C., Campagna, D. R., Schmidt, P. J., Schneider, R. K., Lord, A. M., Wang, L., Gambe, R. G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.006 · Cited by 380 · see citing works
Ogawa, S. (2019) · Blood · doi:10.1182/blood-2018-10-844621 · Cited by 366 · see citing works
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 356 · see citing works
Lee, S. C.-W., Dvinge, H., Kim, E. H., Cho, H., Micol, J., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4097 · Cited by 347 · see citing works
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Sciarrillo, R., Wojtuszkiewicz, A., Assaraf, Y. G., Jansen, G., Kaspers, G. J. L., Giovannetti, E., & Cloos, J. J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100728 · Cited by 311 · see citing works
Splicing-factor alterations in cancers
Anczuków, O., & Krainer, A. R. (2016) · RNA · doi:10.1261/rna.057919.116 · Cited by 297 · see citing works
Chen, L., Chen, J., Huang, Y.-J., Gu, Y., Qiu, J., Qian, H., Shao, C., Zhang, X., Hu, J., Li, H., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.029 · Cited by 295 · see citing works
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Rogalska, M. E., Vivori, C., & Valcárcel, J. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00556-8 · Cited by 269 · see citing works
Smith, M. A., Choudhary, G. S., Pellagatti, A., Choi, K., Bolanos, L. C., Bhagat, T. D., Gordon-Mitchell, S., Ahrens, D. V., Pradhan, K., Steeples, V., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0314-5 · Cited by 247 · see citing works
Pellagatti, A., Armstrong, R. N., Steeples, V., Sharma, E., Repapi, E., Singh, S., Sanchi, A., Radujkovic, A., Horn, P., Dolatshad, H., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843771 · Cited by 240 · see citing works
Wang, E., & Aifantis, I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.011 · Cited by 242 · see citing works
Targeted deep sequencing in primary myelofibrosis
Tefferi, A., Lasho, T. L., Finke, C. M., Elala, Y. C., Hanson, C. A., Ketterling, R. P., Gangat, N., & Pardanani, A. D. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000208 · Cited by 220 · see citing works
RNA Splicing and Disease: Animal Models to Therapies
Montes, M., Sanford, B. L., Comiskey, D. F., & Chandler, D. S. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.10.002 · Cited by 214 · see citing works
Defective control of pre–messenger RNA splicing in human disease
Chabot, B., & Shkreta, L. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 209 · see citing works
Wang, L., Brooks, A. N., Fan, J., Wan, Y., Gambe, R. G., Li, S., Hergert, S., Yin, S., Freeman, S. S., Levin, J. Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.005 · Cited by 208 · see citing works
Pei, W., Shang, F., Wang, X., Fanti, A.-K., Greco, A., Busch, K., Klapproth, K., Zhang, Q., Quedenau, C., Sauer, S., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.07.018 · Cited by 174 · see citing works
Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome
Warren, A. J. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.09.002 · Cited by 177 · see citing works
Shiozawa, Y., Malcovati, L., Gallì, A., Sato‐Otsubo, A., Kataoka, K., Sato, Y., Watatani, Y., Suzuki, H., Yoshizato, T., Yoshida, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06063-x · Cited by 172 · see citing works
Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome
Kennedy, J. A., & Ebert, B. L. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0806 · Cited by 170 · see citing works
Nguyen, H. D., Leong, W. Y., Li, W., Reddy, P. N. G., Sullivan, J. D., Walter, M. J., Zou, L., & Graubert, T. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3970 · Cited by 162 · see citing works
Daguenet, É., Dujardin, G., & Valcárcel, J. (2015) · EMBO Reports · doi:10.15252/embr.201541116 · Cited by 151 · see citing works
Altered RNA Processing in Cancer Pathogenesis and Therapy
Obeng, E. A., Stewart, C., & Abdel-Wahab, O. I. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0399 · Cited by 141 · see citing works
Splicing factor gene mutations in hematologic malignancies
Sáez, B., Walter, M. J., & Graubert, T. A. (2016) · Blood · doi:10.1182/blood-2016-10-692400 · Cited by 130 · see citing works
Emerging roles of spliceosome in cancer and immunity
Yang, H., Beutler, B., & Zhang, D. (2021) · Protein & Cell · doi:10.1007/s13238-021-00856-5 · Cited by 134 · see citing works
Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones
Challen, G., & Goodell, M. A. (2020) · Blood · doi:10.1182/blood.2020006510 · Cited by 131 · see citing works
Mupo, A., Seiler, M., Sathiaseelan, V., Pance, A., Yang, Y., Agrawal, A. A., Iorio, F., Bautista, R., Pacharne, S., Tzelepis, K., et al. (2016) · Leukemia · doi:10.1038/leu.2016.251 · Cited by 122 · see citing works
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1
Zhang, J., Ali, A. M., Lieu, Y. K., Liu, Z., Gao, J., Rabadán, R., Raza, A., Mukherjee, S., & Manley, J. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.017 · Cited by 124 · see citing works
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Shirai, C. L., White, B. S., Tripathi, M., TAPIA-CONYER, R. C., Ley, J. N., Ndonwi, M., Kim, S. P., Shao, J., Carver, A., Sáez, B., et al. (2017) · Nature Communications · doi:10.1038/ncomms14060 · Cited by 118 · see citing works
Jan, M., Ebert, B. L., & Jaiswal, S. (2016) · Seminars in hematology (Print) · doi:10.1053/j.seminhematol.2016.10.002 · Cited by 130 · see citing works
Inoue, D., Bradley, R. K., & Abdel-Wahab, O. I. (2016) · Genes & Development · doi:10.1101/gad.278424.116 · Cited by 109 · see citing works
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition
Inoue, D., Polaski, J. T., Taylor, J., Castel, P., Chen, S., Kobayashi, S. S., Hogg, S. J., Hayashi, Y., Pineda, J. M. B., Marabti, E. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00828-9 · Cited by 107 · see citing works
Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms
Grinfeld, J., Nangalia, J., & Green, A. R. (2016) · Haematologica · doi:10.3324/haematol.2014.113845 · Cited by 102 · see citing works
Splicing factor mutations in hematologic malignancies
Chen, S., Benbarche, S., & Abdel-Wahab, O. I. (2021) · Blood · doi:10.1182/blood.2019004260 · Cited by 104 · see citing works
Liang, Y., Tebaldi, T., Rejeski, K., Joshi, P. M., Stefani, G., Taylor, A., Song, Y., Vasic, R., Maziarz, J. D., Balasubramanian, K., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0152-7 · Cited by 96 · see citing works
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Yip, B. H., Steeples, V., Repapi, E., Armstrong, R. N., Llorian, M., Roy, S., Shaw, J. M., Dolatshad, H., Taylor, S., Verma, A. K., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91363 · Cited by 97 · see citing works
Emerging concepts of epigenetic dysregulation in hematological malignancies
Ntziachristos, P., Abdel-Wahab, O. I., & Aifantis, I. (2016) · Nature Immunology · doi:10.1038/ni.3517 · Cited by 96 · see citing works
Fei, D. L., Motowski, H., Chatrikhi, R., Prasad, S., Yu, J., Gao, S., Kielkopf, C. L., Bradley, R. K., & VARMUS, H. E. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006384 · Cited by 90 · see citing works
Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation
Gondek, L. P., Zheng, G., Ghiaur, G., Dezern, A. E., Matsui, W. H., Yegnasubramanian, S., Lin, M.-T., Levis, M. J., Eshleman, J. R., Varadhan, R., et al. (2016) · Leukemia · doi:10.1038/leu.2016.63 · Cited by 90 · see citing works
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Taylor, J., & Lee, S. C.-W. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22784 · Cited by 85 · see citing works
The role of RNA alternative splicing in regulating cancer metabolism
Kozlovski, I., Siegfried, Z., Amar-Schwartz, A., & Karni, R. (2017) · Human Genetics · doi:10.1007/s00439-017-1803-x · Cited by 83 · see citing works
Kon, A., Yamazaki, S., Nannya, Y., Kataoka, K., Ota, Y., Nakagawa, M. M., Yoshida, K., Shiozawa, Y., Morita, M., Yoshizato, T., et al. (2017) · Blood · doi:10.1182/blood-2017-01-762393 · Cited by 83 · see citing works
Molecular impact of mutations in RNA splicing factors in cancer
Zhang, Q., Ai, Y., & Abdel-Wahab, O. I. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.07.019 · Cited by 79 · see citing works
Gañán‐Gómez, I., Yang, H., Ma, F., Bravo, G. M., Thongon, N., Marchica, V., Richard‐Carpentier, G., Chien, K. S., Manyam, G. C., Wang, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01696-4 · Cited by 80 · see citing works
Splicing heterogeneity: separating signal from noise
Wan, Y., & Larson, D. R. (2018) · Genome biology · doi:10.1186/s13059-018-1467-4 · Cited by 79 · see citing works
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia
Zhou, Y., Han, C., Wang, E., Lorch, A. H., Serafin, V., Cho, B.-K., Gutierrez-Diaz, B. T., Calvo, J., Fang, C., Khodadadi‐Jamayran, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1436 · Cited by 78 · see citing works
Biancon, G., Joshi, P. M., Zimmer, J. T., Hunck, T., Gao, Y., Lessard, M. D., Courchaine, E. M., Barentine, A. E. S., Machyna, M., Botti, V., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.025 · Cited by 78 · see citing works
SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression
Kawamura, N., Nimura, K., Saga, K., Ishibashi, A., Kitamura, K., Nagano, H., Yoshikawa, Y., Ishida, K., Nonomura, N., Arisawa, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3965 · Cited by 78 · see citing works
A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer
de Miguel, F. J., Pajares, M. J., Martínez‐Terroba, E., Ajona, D., Morales, X., Sharma, R. D., Pardo, F. J., Rouzaut, A., Rubio, Á., Montuenga, L. M., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.08.001 · Cited by 76 · see citing works
A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies
Inoue, D., Fujino, T., Sheridan, P. J., Zhang, Y., Nagase, R., Horikawa, S., Li, Z., Matsui, H., Kanai, A., Saika, M., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0083-3 · Cited by 78 · see citing works
Visconte, V., Nakashima, M. O., & Rogers, H. J. (2019) · Cancers · doi:10.3390/cancers11121844 · Cited by 74 · see citing works
Pronk, E., & Raaijmakers, M. H. G. P. (2019) · Blood · doi:10.1182/blood-2018-10-844639 · Cited by 72 · see citing works
Bamopoulos, S. A., Batcha, A. M. N., Jurinović, V., Rothenberg‐Thurley, M., Janke, H., Ksienzyk, B., Philippou‐Massier, J., Graf, A., Krebs, S., Blum, H., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0839-4 · Cited by 76 · see citing works
Fei, D. L., Zhen, T., Durham, B. H., Ferrarone, J. R., Zhang, T., Garrett, L. J., Yoshimi, A., Abdel-Wahab, O. I., Bradley, R. K., Liu, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812669115 · Cited by 68 · see citing works
Handschuh, L. (2019) · Journal of Oncology · doi:10.1155/2019/7239206 · Cited by 65 · see citing works
Rinke, J., Chase, A., Cross, N. C. P., Hochhaus, A., & Ernst, T. (2020) · Cells · doi:10.3390/cells9071639 · Cited by 66 · see citing works
Li, B., Liu, J., Jia, Y., Wang, J., Xu, Z., Qin, T., Shi, Z., Song, Z., Peng, S., Huang, H., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22510 · Cited by 66 · see citing works
Cheruiyot, A., Li, S., Srivatsan, S. N., Ahmed, T., Chen, Y., Lemacon, D. S., Li, Y., Yang, Z., Wadugu, B. A., Warner, W. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4016 · Cited by 60 · see citing works
PEG10 promotes human breast cancer cell proliferation, migration and invasion
Li, X., Xiao, R., Tembo, K. M., Hao, L., Xiong, M., Pan, S., Yang, X., Yuan, W., Xiong, J., & Zhang, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3406 · Cited by 61 · see citing works
Spinella, J.-F., Cassart, P., Richer, C., Saillour, V., Ouimet, M., Langlois, S., St-Onge, P., Sontag, T., Healy, J., Minden, M. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11796 · Cited by 60 · see citing works
Ball, M., List, A. F., & Padron, E. (2016) · Blood · doi:10.1182/blood-2016-07-692988 · Cited by 57 · see citing works
Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role
Shen, S.-M., Ji, Y., Zhang, C., Dong, S.-S., Yang, S., Xiong, Z., Ge, M.-K., Yu, Y., Li, X., Guo, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04760-1 · Cited by 59 · see citing works
Complex landscape of alternative splicing in myeloid neoplasms
Hershberger, C. E., Moyer, D. C., Ademà, V., Kerr, C. M., Walter, W., Hütter, S., Meggendorfer, M., Baer, C. R., Kern, W., Nadarajah, N., et al. (2020) · Leukemia · doi:10.1038/s41375-020-1002-y · Cited by 57 · see citing works
Wheeler, E. C., Vora, S., Mayer, D., Kotini, A. G., Olszewska, M., Park, S. S., Guccione, E., Teruya‐Feldstein, J., Silverman, L. R., Sunahara, R. K., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0508 · Cited by 53 · see citing works
Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Vigevani, L., Gohr, A., Webb, T. R., Irimia, M., & Valcárcel, J. (2017) · Nature Communications · doi:10.1038/s41467-017-02007-z · Cited by 54 · see citing works
Tanaka, I., Chakraborty, A., Saulnier, O., Benoit‐Pilven, C., Vacher, S., Labiod, D., Lam, E. W. ‐., Bièche, I., Delattre, O., Pouzoulet, F., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1213 · Cited by 53 · see citing works
Clonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 56 · see citing works
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
Castelli, G., Pelosi, E., & Testa, U. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145971 · Cited by 51 · see citing works
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
Esfahani, M. S., Lee, L. J., Jeon, Y.-J., Flynn, R. A., Stehr, H., Hui, A. B., Ishisoko, N., Kildebeck, E., Newman, A. M., Bratman, S. V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13392-y · Cited by 50 · see citing works
Wu, L., Song, L., Xu, L. P., Chang, C., Xu, F., Wu, D., He, Q., Su, J., Zhou, L., Xiao, C., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4305-2 · Cited by 49 · see citing works
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Marzese, D. M., Manughian-Peter, A. O., Orozco, J. I. J., & Hoon, D. S. �. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9905-y · Cited by 47 · see citing works
Wang, Y., Bao, Y., Zhang, S., & Wang, Z. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1605-0 · Cited by 44 · see citing works
Cazzola, M., & Malcovati, L. (2015) · Hematology · doi:10.1182/asheducation-2015.1.19 · Cited by 44 · see citing works
Pai, A. A., & Luca, F. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1503 · Cited by 47 · see citing works
Pathogenesis of Myeloproliferative Disorders
Nangalia, J., Grinfeld, J., & Green, A. R. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044454 · Cited by 43 · see citing works
The functional mechanisms of mutations in myelodysplastic syndrome
Nagata, Y., & Maciejewski, J. P. (2019) · Leukemia · doi:10.1038/s41375-019-0617-3 · Cited by 42 · see citing works
U2af1 is required for survival and function of hematopoietic stem/progenitor cells
Dutta, A., Yang, Y., Le, B. T., Zhang, Y., Abdel-Wahab, O. I., Zang, C., & Mohi, G. (2021) · Leukemia · doi:10.1038/s41375-020-01116-x · Cited by 44 · see citing works
Prevalent intron retention fine‐tunes gene expression and contributes to cellular senescence
Yao, J., Ding, D., Li, X., Shen, T., Fu, H., Zhong, J., Wei, G., & Ni, T. (2020) · Aging Cell · doi:10.1111/acel.13276 · Cited by 42 · see citing works
Skov, V. (2020) · Cancers · doi:10.3390/cancers12082194 · Cited by 40 · see citing works
Alternative splicing in aging and age-related diseases
Li, H., Wang, Z., Ma, T., Wei, G., & Ni, T. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.09.005 · Cited by 39 · see citing works
Regulatory Potential of the RNA Processing Machinery: Implications for Human Disease
Carey, K. T., & Wickramasinghe, V. O. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.12.012 · Cited by 39 · see citing works
Recent insights regarding the molecular basis of myeloproliferative neoplasms
Jang, M., & Choi, C. W. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.317 · Cited by 41 · see citing works
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
Kitamura, K., & Nimura, K. (2021) · Cells · doi:10.3390/cells10040923 · Cited by 38 · see citing works
Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence
Miller, C. A., Walker, J., Jensen, T. L., Hooper, W. F., Fulton, R. S., Painter, J. S., Sekeres, M. A., Ley, T. J., Spencer, D. H., Goll, J. B., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.10.013 · Cited by 38 · see citing works
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita
Kirschner, M., Maurer, A., Włodarski, M. W., Ferreira, M. S. V., Bouillon, A., Halfmeyer, I., Blau, W., Kreuter, M., Rosewich, M., Corbacioglu, S., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0125-x · Cited by 37 · see citing works
We skip to work: alternative splicing in normal and malignant myelopoiesis
Wong, A. C. H., Rasko, J. E. J., & Wong, J. J. L. (2018) · Leukemia · doi:10.1038/s41375-018-0021-4 · Cited by 35 · see citing works
Splicing accuracy varies across human introns, tissues, age and disease
García-Ruiz, S., Zhang, D., Gustavsson, E. K., Rocamora-Perez, G., Grant‐Peters, M., Fairbrother-Browne, A., Reynolds, R. H., Brenton, J., Gil-Martínez, A. L., Chen, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55607-x · Cited by 33 · see citing works
- Authors
- Shirai, C. L., Ley, J. N., White, B. S., Kim, S., Tibbitts, J., Shao, J., Ndonwi, M., Wadugu, B., Duncavage, E. J., Okeyo-Owuor, T., Liu, T., Griffith, M., McGrath, S., Magrini, V., Fulton, R. S., Fronick, C., O’Laughlin, M., Graubert, T. A., & Walter, M. J.
- Affiliations
- Washington University in St. Louis (US)
- Harvard University (US)
- Corresponding author
- Walter, Matthew J.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 27
- Issue
- 5
- Pages
- 631-643
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4430854
- OpenAlex
- W1536775300
- Cited by
- 287
- References
- 54
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 18 · 2023: 30 · 2022: 20 · 2021: 30 · 2020: 32 · 2019: 33 · 2018: 24 · 2017: 26 · 2016: 32 · 2015: 13
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000448)
- National Heart, Lung, and Blood Institute (K12HL087107, T32HL007088)
- National Cancer Institute (T32CA113275, P50CA171963, P30CA091842, K12CA167540)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- U2AF1, myelodysplastic syndrome, pre-mRNA splicing, hematopoiesis, hematopoietic progenitor cells, spliceosome, acute myeloid leukemia, ribosomal genes, RNA processing genes
- MeSH terms
- Splicing Factor U2AF, Animals, Hematopoiesis, Humans, Mice, Transgenic, Mutation, Myelodysplastic Syndromes, Nuclear Proteins, Ribonucleoproteins, RNA Precursors, RNA Splicing, RNA, Messenger, Leukemia, Myeloid, Acute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
